266 related articles for article (PubMed ID: 20919962)
1. Second AKT: the rise of SGK in cancer signalling.
Bruhn MA; Pearson RB; Hannan RD; Sheppard KE
Growth Factors; 2010 Dec; 28(6):394-408. PubMed ID: 20919962
[TBL] [Abstract][Full Text] [Related]
2. Coordinate expression of the PI3-kinase downstream effectors serum and glucocorticoid-induced kinase (SGK-1) and Akt-1 in human breast cancer.
Sahoo S; Brickley DR; Kocherginsky M; Conzen SD
Eur J Cancer; 2005 Nov; 41(17):2754-9. PubMed ID: 16246546
[TBL] [Abstract][Full Text] [Related]
3. mTOR and Akt signaling in cancer: SGK cycles in.
Toker A
Mol Cell; 2008 Jul; 31(1):6-8. PubMed ID: 18614042
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a).
Brunet A; Park J; Tran H; Hu LS; Hemmings BA; Greenberg ME
Mol Cell Biol; 2001 Feb; 21(3):952-65. PubMed ID: 11154281
[TBL] [Abstract][Full Text] [Related]
5. Serum and glucocorticoid-regulated protein kinases: variations on a theme.
Tessier M; Woodgett JR
J Cell Biochem; 2006 Aug; 98(6):1391-407. PubMed ID: 16619268
[TBL] [Abstract][Full Text] [Related]
6. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369
[TBL] [Abstract][Full Text] [Related]
7. Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2.
Kobayashi T; Cohen P
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):319-28. PubMed ID: 10191262
[TBL] [Abstract][Full Text] [Related]
8. PLC and PI3K/Akt/mTOR signalling in disease and cancer.
Follo MY; Manzoli L; Poli A; McCubrey JA; Cocco L
Adv Biol Regul; 2015 Jan; 57():10-6. PubMed ID: 25482988
[TBL] [Abstract][Full Text] [Related]
9. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
10. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms.
Lang F; Böhmer C; Palmada M; Seebohm G; Strutz-Seebohm N; Vallon V
Physiol Rev; 2006 Oct; 86(4):1151-78. PubMed ID: 17015487
[TBL] [Abstract][Full Text] [Related]
11. Role of hypoxia-induced fibronectin-integrin β1 expression in embryonic stem cell proliferation and migration: Involvement of PI3K/Akt and FAK.
Lee SH; Lee YJ; Han HJ
J Cell Physiol; 2011 Feb; 226(2):484-93. PubMed ID: 20677223
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of LAPTM4B-35 promotes malignant transformation and tumorigenesis in L02 human liver cell line.
Li L; Shan Y; Yang H; Zhang S; Lin M; Zhu P; Chen XY; Yi J; McNutt MA; Shao GZ; Zhou RL
Anat Rec (Hoboken); 2011 Jul; 294(7):1135-42. PubMed ID: 21618708
[TBL] [Abstract][Full Text] [Related]
13. Effects of the RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells.
Shelton JG; Steelman LS; Lee JT; Knapp SL; Blalock WL; Moye PW; Franklin RA; Pohnert SC; Mirza AM; McMahon M; McCubrey JA
Oncogene; 2003 Apr; 22(16):2478-92. PubMed ID: 12717425
[TBL] [Abstract][Full Text] [Related]
14. PKB/Akt-dependent regulation of cell motility.
Xue G; Hemmings BA
J Natl Cancer Inst; 2013 Mar; 105(6):393-404. PubMed ID: 23355761
[TBL] [Abstract][Full Text] [Related]
15. Loss of serum and glucocorticoid-regulated kinase 3 (SGK3) does not affect proliferation and survival of multiple myeloma cell lines.
Hausmann S; Brandt E; Köchel C; Einsele H; Bargou RC; Seggewiss-Bernhardt R; Stühmer T
PLoS One; 2015; 10(4):e0122689. PubMed ID: 25837824
[TBL] [Abstract][Full Text] [Related]
16. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression.
Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA
Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392
[TBL] [Abstract][Full Text] [Related]
17. PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival.
Coutant A; Rescan C; Gilot D; Loyer P; Guguen-Guillouzo C; Baffet G
Hepatology; 2002 Nov; 36(5):1079-88. PubMed ID: 12395317
[TBL] [Abstract][Full Text] [Related]
18. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
[TBL] [Abstract][Full Text] [Related]
19. The serum- and glucocorticoid-inducible kinase Sgk-1 is involved in pulmonary vascular remodeling: role in redox-sensitive regulation of tissue factor by thrombin.
BelAiba RS; Djordjevic T; Bonello S; Artunc F; Lang F; Hess J; Görlach A
Circ Res; 2006 Mar; 98(6):828-36. PubMed ID: 16484615
[TBL] [Abstract][Full Text] [Related]
20. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]